Includes bibliographical references.
|Statement||editors, William T. Abraham, Ragavendra R. Baliga.|
|Contributions||Abraham, William T., Baliga, R. R.|
|LC Classifications||RC685.C53 C38 2010|
|The Physical Object|
|LC Control Number||2009032206|
Purpose: Ventricular dyssynchrony plays a major role in the pathogenesis and progression of heart failure. This book covers this very important topic, its identification, and the role of cardiac resynchronization therapy in treating patients with heart : $ This new edition of the successful Cardiac Resynchronization Therapy builds on the strengths of the first edition, providing basic knowledge as well as an up-to-date summary of new advances in CRT for heart failure. Heart failure is the fastest growing cardiovascular diagnosis in North America, and it carries a poor prognosis.1, 2 To improve survival in heart failure patients, therapies need to reduce either sudden cardiac death (the most common cause of death in patients with New York Heart Association [NYHA] Class I or II symptoms) or progressive heart failure Cited by: 1. Written by noted experts with day-to-day experience in cardiac resynchronization therapy (CRT), this comprehensive, practical reference gives physicians a thorough knowledge of the indications, techniques for implantation, complications, programming, and follow-up of CRT devices in patients with heart failure Brand: Wolters Kluwer Health.
ISBN: OCLC Number: Description: ix, pages: illustrations (some color) ; 29 cm: Contents: Pathophysiology of ventricular dyssynchrony and mechanisms of cardiac resynchronization therapy / Robert H. Helm [and others] --Clinical predictors of improvement in left ventricular performance with cardiac resynchronization therapy . Therefore, treatment of heart failure is a primary focus of cardiovascular disease management strategies. Cardiac Resynchronization Therapy provides basic knowledge about congestive heart failure but also covers the evolution of cardiac resynchronization therapy Price: $ Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart Author: Michael A. Samara, David S. Feldman. Cardiac Resynchronization Therapy in Heart Failure is a book that is attractive and understandable for many medical professionals involved in the treatment of heart failure, whether or not they are already involved in treating patients with CRT. It provides exactly what is promised in the title: a comprehensive state-of-the-art overview of how CRT should be used in heart failure Author: Frits W. Prinzen.
Written by noted experts with day-to-day experience in cardiac resynchronization therapy (CRT), this comprehensive, practical reference gives physicians a thorough knowledge of the indications, techniques for implantation, complications, programming, and follow-up of CRT devices in patients with heart failure and intra . Cardiac Resynchronization Therapy continues to evolve at a rapid pace. Growing clinical experience and additional clinical trials are resulting in changes in how patients are selected for CRT. This new edition of the successful Cardiac Resynchronization Therapy . The benefits of cardiac resynchronization therapy (CRT) have been firmly established in heart failure (HF) patients who remain in New York Heart Association (NYHA) functional classes II and III, despite optimal medical therapy . Cardiac resynchronization therapy is a treatment for heart failure in people whose ventricles don't contract in a coordinated fashion. If you have heart failure, your heart muscle is .